BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16632547)

  • 1. Partial expression defect for the SCN5A missense mutation G1406R depends on splice variant background Q1077 and rescue by mexiletine.
    Tan BH; Valdivia CR; Song C; Makielski JC
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1822-8. PubMed ID: 16632547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression defect of the rare variant/Brugada mutation R1512W depends upon the SCN5A splice variant background and can be rescued by mexiletine and the common polymorphism H558R.
    Hu RM; Song EJ; Tester DJ; Deschenes I; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2021 Dec; 15(1):253-261. PubMed ID: 33535892
    [No Abstract]   [Full Text] [Related]  

  • 3. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.
    Makielski JC; Ye B; Valdivia CR; Pagel MD; Pu J; Tester DJ; Ackerman MJ
    Circ Res; 2003 Oct; 93(9):821-8. PubMed ID: 14500339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del.
    Cheng J; Morales A; Siegfried JD; Li D; Norton N; Song J; Gonzalez-Quintana J; Makielski JC; Hershberger RE
    Clin Transl Sci; 2010 Dec; 3(6):287-94. PubMed ID: 21167004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants.
    Tan BH; Valdivia CR; Rok BA; Ye B; Ruwaldt KM; Tester DJ; Ackerman MJ; Makielski JC
    Heart Rhythm; 2005 Jul; 2(7):741-7. PubMed ID: 15992732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3.
    Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG
    Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103Y.
    Plant LD; Bowers PN; Liu Q; Morgan T; Zhang T; State MW; Chen W; Kittles RA; Goldstein SA
    J Clin Invest; 2006 Feb; 116(2):430-5. PubMed ID: 16453024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene.
    Poelzing S; Forleo C; Samodell M; Dudash L; Sorrentino S; Anaclerio M; Troccoli R; Iacoviello M; Romito R; Guida P; Chahine M; Pitzalis M; DeschĂȘnes I
    Circulation; 2006 Aug; 114(5):368-76. PubMed ID: 16864729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel.
    Wang DW; Crotti L; Shimizu W; Pedrazzini M; Cantu F; De Filippo P; Kishiki K; Miyazaki A; Ikeda T; Schwartz PJ; George AL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):370-8. PubMed ID: 19808432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
    Valdivia CR; Tester DJ; Rok BA; Porter CB; Munger TM; Jahangir A; Makielski JC; Ackerman MJ
    Cardiovasc Res; 2004 Apr; 62(1):53-62. PubMed ID: 15023552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced current density, partially rescued by mexiletine, and depolarizing shift in activation of SCN5A W374G channels as a cause of severe form of Brugada syndrome.
    Nakajima T; Dharmawan T; Kawabata-Iwakawa R; Tamura S; Hasegawa H; Kobari T; Ota M; Tange S; Nishiyama M; Kaneko Y; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12828. PubMed ID: 33463855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia.
    Nguyen TP; Wang DW; Rhodes TH; George AL
    Circ Res; 2008 Feb; 102(3):364-71. PubMed ID: 18048769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients.
    Hu RM; Tester DJ; Li R; Sun T; Peterson BZ; Ackerman MJ; Makielski JC; Tan BH
    Channels (Austin); 2018; 12(1):176-186. PubMed ID: 29983085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis.
    Hu RM; Tan BH; Tester DJ; Song C; He Y; Dovat S; Peterson BZ; Ackerman MJ; Makielski JC
    PLoS One; 2015; 10(4):e0124921. PubMed ID: 25923670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations.
    Shinlapawittayatorn K; Du XX; Liu H; Ficker E; Kaufman ES; DeschĂȘnes I
    Heart Rhythm; 2011 Mar; 8(3):455-62. PubMed ID: 21109022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy.
    Saito YA; Strege PR; Tester DJ; Locke GR; Talley NJ; Bernard CE; Rae JL; Makielski JC; Ackerman MJ; Farrugia G
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G211-8. PubMed ID: 19056759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
    Samani K; Wu G; Ai T; Shuraih M; Mathuria NS; Li Z; Sohma Y; Purevjav E; Xi Y; Towbin JA; Cheng J; Vatta M
    Heart Rhythm; 2009 Sep; 6(9):1318-26. PubMed ID: 19648062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients.
    Ruan Y; Liu N; Bloise R; Napolitano C; Priori SG
    Circulation; 2007 Sep; 116(10):1137-44. PubMed ID: 17698727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.